Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Blurry Copies | Main | Tarceva Targets »

December 5, 2004

Beg to Differ

Email This Entry

Posted by Derek

There was a comment to the "Some Perspective" post from last week that I wanted to address out here in a more public area. Said the reader:

"This industry (has) lost itself to profit. Every decision made was (a) business decision in every company. Employees are robots, have no creativity, and very little interest in science."

Well, I recognize when someone's been having a bad day. I have 'em myself. But with all due respect, I'm glad to say that this particular comment is wrong, from top to bottom. It's wrong in different parts for different reasons, though, and it's worth taking a minute to examine them.

Let's take the last part first. No one who works for me is an uncreative robot uninterested in science. Not for long, anyway. Either that attitude changes or (more likely) I find a way to shift them out of my lab or out of the company. I'm as interested in science as I am anything in the world, and while I don't expect everyone to go that far, I can't stand working with people who view their research job the same way they'd view working at the tuna packing plant.

Every research project has moments that make you respect the fact that you're working with something bigger than you are and more complicated than you understand. If you don't have those once in a while, you're not doing research. We all have to crank out a series of by-the-numbers compounds sometimes, sure, the good ol' methyl-ethyl-butyl-futyl. But if that's all you're doing, all the time, then you should be replaced by some sort of automated synthesizer as fast as possible.

Naturally, I also understand that many drug development projects don't have the time or the resources to pursue all the pure science questions that they could. There's pressure to produce results, and you sometimes have to be ruthless about what you pursue. But even on the main path of every project, you'll find enough reversals, strange results, and sudden breakthroughs to keep you sharp.

Now let's take on the first part of the comment, about all those decisions being business decisions. You've got that right! But that's a bit like saying that all novels get written by people who write. The drug business is, yes indeed, a business. If we don't make money, we don't get to discover any drugs. It's that tension that makes it such a challenge, and it's the same tension that keeps us moving at a faster research pace than any similar academic efforts. We know that other hard-hearted businesses are coming to eat our lunch if we don't find something that someone wants to buy. Capitalism's brutal. That's what makes it work.

Comments (1) + TrackBacks (0) | Category: Life in the Drug Labs


COMMENTS

1. biff on December 5, 2004 10:07 PM writes...

Preach on, Brother Lowe!

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Scripps Update
What If Drug Patents Were Written Like Software Patents?
Stem Cells: The Center of "Right to Try"
Speaking of Polyphenols. . .
Dark Biology And Small Molecules
How Polyphenols Work, Perhaps?
More On Automated Medicinal Chemistry
Scripps Merging With USC?